Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura.

Blood

Tarasco E, Bütikofer L, Friedman KD, George JN, Hrachovinova I, Knöbl PN, Matsumoto M, von Krogh AS, Aebi-Huber I, Cermakova Z, Górska-Kosicka M, Jalowiec KA, Largiadèr CR, Prohászka Z, Sinkovits G, Windyga J, Lämmle B, Kremer Hovinga JA.
PMID: 33649760
Blood. 2021 Jun 24;137(25):3563-3575. doi: 10.1182/blood.2020009801.

Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare thrombotic microangiopathy characterized by severe congenital ADAMTS13 deficiency and recurring acute episodes causing morbidity and premature death. Information on the annual incidence and severity of acute episodes in patients with hTTP...

Cite
Tarasco E, Bütikofer L, Friedman KD, et al. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021;137(25):3563-3575doi: 10.1182/blood.2020009801.
Tarasco, E., Bütikofer, L., Friedman, K. D., George, J. N., Hrachovinova, I., Knöbl, P. N., Matsumoto, M., von Krogh, A. S., Aebi-Huber, I., Cermakova, Z., Górska-Kosicka, M., Jalowiec, K. A., Largiadèr, C. R., Prohászka, Z., Sinkovits, G., Windyga, J., Lämmle, B., & Kremer Hovinga, J. A. (2021). Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood, 137(25), 3563-3575. https://doi.org/10.1182/blood.2020009801
Tarasco, Erika, et al. "Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura." Blood vol. 137,25 (2021): 3563-3575. doi: https://doi.org/10.1182/blood.2020009801
Tarasco E, Bütikofer L, Friedman KD, George JN, Hrachovinova I, Knöbl PN, Matsumoto M, von Krogh AS, Aebi-Huber I, Cermakova Z, Górska-Kosicka M, Jalowiec KA, Largiadèr CR, Prohászka Z, Sinkovits G, Windyga J, Lämmle B, Kremer Hovinga JA. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021 Jun 24;137(25):3563-3575. doi: 10.1182/blood.2020009801. PMID: 33649760.
Copy Download .nbib Format: NLM
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis.

Frontiers in genetics

Cismaru AL, Grimm L, Rudin D, Ibañez L, Liakoni E, Bonadies N, Kreutz R, Hallberg P, Wadelius M, Haschke M, Largiadèr CR, Amstutz U.
PMID: 32973882
Front Genet. 2020 Aug 21;11:951. doi: 10.3389/fgene.2020.00951. eCollection 2020.

No abstract available.

Cite
Cismaru AL, Grimm L, Rudin D, et al. High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis. Front Genet. 2020;11:951doi: 10.3389/fgene.2020.00951.
Cismaru, A. L., Grimm, L., Rudin, D., Ibañez, L., Liakoni, E., Bonadies, N., Kreutz, R., Hallberg, P., Wadelius, M., Haschke, M., Largiadèr, C. R., & Amstutz, U. (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis. Frontiers in genetics, 11951. https://doi.org/10.3389/fgene.2020.00951
Cismaru, Anca Liliana, et al. "High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis." Frontiers in genetics vol. 11 (2020): 951. doi: https://doi.org/10.3389/fgene.2020.00951
Cismaru AL, Grimm L, Rudin D, Ibañez L, Liakoni E, Bonadies N, Kreutz R, Hallberg P, Wadelius M, Haschke M, Largiadèr CR, Amstutz U. High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis. Front Genet. 2020 Aug 21;11:951. doi: 10.3389/fgene.2020.00951. eCollection 2020. PMID: 32973882; PMCID: PMC7473498.
Copy Download .nbib Format: NLM
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.

Allergy

Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M.
PMID: 34986501
Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05.

BACKGROUND: Serological tests are a powerful tool in the monitoring of infectious diseases and the detection of host immunity. However, manufacturers often provide diagnostic accuracy data generated through biased studies, and the performance in clinical practice is essentially unclear.OBJECTIVES:...

Cite
Horn MP, Jonsdottir HR, Brigger D, et al. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study. Allergy. 2022;doi: 10.1111/all.15206.
Horn, M. P., Jonsdottir, H. R., Brigger, D., Damonti, L., Suter-Riniker, F., Endrich, O., Froehlich, T. K., Fiedler, M., Largiadèr, C. R., Marschall, J., Weber, B., Eggel, A., & Nagler, M. (2022). Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study. Allergy, . https://doi.org/10.1111/all.15206
Horn, Michael P, et al. "Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study." Allergy vol. (2022). doi: https://doi.org/10.1111/all.15206
Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study. Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05. PMID: 34986501.
Copy Download .nbib Format: NLM
An SSP-PCR method for the rapid detection of disease-associated alleles HLA-A*29 and HLA-B*51.

HLA

Amstutz U, Schaerer D, Andrey G, Wirthmueller U, Largiadèr CR.
PMID: 29766667
HLA. 2018 May 15; doi: 10.1111/tan.13296. Epub 2018 May 15.

HLA-A*29 and HLA-B*51 are associated with birdshot uveitis and Behçet's disease, respectively, and are used as a diagnostic criterion in patients with suspected disease, requiring their detection in diagnostic laboratories. While commercial tests for individual HLA alleles are available...

Cite
Amstutz U, Schaerer D, Andrey G, et al. An SSP-PCR method for the rapid detection of disease-associated alleles HLA-A*29 and HLA-B*51. HLA. 2018;doi: 10.1111/tan.13296.
Amstutz, U., Schaerer, D., Andrey, G., Wirthmueller, U., & Largiadèr, C. R. (2018). An SSP-PCR method for the rapid detection of disease-associated alleles HLA-A*29 and HLA-B*51. HLA, . https://doi.org/10.1111/tan.13296
Amstutz, U, et al. "An SSP-PCR method for the rapid detection of disease-associated alleles HLA-A*29 and HLA-B*51." HLA vol. (2018). doi: https://doi.org/10.1111/tan.13296
Amstutz U, Schaerer D, Andrey G, Wirthmueller U, Largiadèr CR. An SSP-PCR method for the rapid detection of disease-associated alleles HLA-A*29 and HLA-B*51. HLA. 2018 May 15; doi: 10.1111/tan.13296. Epub 2018 May 15. PMID: 29766667.
Copy Download .nbib Format: NLM
Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration.

NPJ genomic medicine

Zysset-Burri DC, Keller I, Berger LE, Largiadèr CR, Wittwer M, Wolf S, Zinkernagel MS.
PMID: 34465794
NPJ Genom Med. 2020 Sep 01;5(1):34. doi: 10.1038/s41525-020-00141-0.

Age-related macular degeneration (AMD) is a leading cause of severe vision loss in the aged population. The etiology of AMD is multifactorial including nutritional factors, genetic variants mainly in the complement pathway, environmental risk factors and alterations in the...

Cite
Zysset-Burri DC, Keller I, Berger LE, et al. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med. 2020;5(1):34doi: 10.1038/s41525-020-00141-0.
Zysset-Burri, D. C., Keller, I., Berger, L. E., Largiadèr, C. R., Wittwer, M., Wolf, S., & Zinkernagel, M. S. (2020). Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ genomic medicine, 5(1), 34. https://doi.org/10.1038/s41525-020-00141-0
Zysset-Burri, Denise C, et al. "Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration." NPJ genomic medicine vol. 5,1 (2020): 34. doi: https://doi.org/10.1038/s41525-020-00141-0
Zysset-Burri DC, Keller I, Berger LE, Largiadèr CR, Wittwer M, Wolf S, Zinkernagel MS. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med. 2020 Sep 01;5(1):34. doi: 10.1038/s41525-020-00141-0. PMID: 34465794.
Copy Download .nbib Format: NLM
Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration.

NPJ genomic medicine

Zysset-Burri DC, Keller I, Berger LE, Largiadèr CR, Wittwer M, Wolf S, Zinkernagel MS.
PMID: 32922859
NPJ Genom Med. 2020 Sep 01;5:34. doi: 10.1038/s41525-020-00141-0. eCollection 2020.

Age-related macular degeneration (AMD) is a leading cause of severe vision loss in the aged population. The etiology of AMD is multifactorial including nutritional factors, genetic variants mainly in the complement pathway, environmental risk factors and alterations in the...

Cite
Zysset-Burri DC, Keller I, Berger LE, et al. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med. 2020;5:34doi: 10.1038/s41525-020-00141-0.
Zysset-Burri, D. C., Keller, I., Berger, L. E., Largiadèr, C. R., Wittwer, M., Wolf, S., & Zinkernagel, M. S. (2020). Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ genomic medicine, 534. https://doi.org/10.1038/s41525-020-00141-0
Zysset-Burri, Denise C, et al. "Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration." NPJ genomic medicine vol. 5 (2020): 34. doi: https://doi.org/10.1038/s41525-020-00141-0
Zysset-Burri DC, Keller I, Berger LE, Largiadèr CR, Wittwer M, Wolf S, Zinkernagel MS. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med. 2020 Sep 01;5:34. doi: 10.1038/s41525-020-00141-0. eCollection 2020. PMID: 32922859; PMCID: PMC7463023.
Copy Download .nbib Format: NLM
A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies.

Journal of personalized medicine

Schaerer D, Froehlich TK, Hamzic S, Offer SM, Diasio RB, Joerger M, Amstutz U, Largiadèr CR.
PMID: 33086767
J Pers Med. 2020 Oct 19;10(4). doi: 10.3390/jpm10040181.

Inhibition of thymidylate synthase (TS) is the primary mode of action for 5-fluorouracil (5FU) chemotherapy. TS expression is modulated by a variable number of tandem repeats in the TS enhancer region (TSER) located upstream of the TS gene (

Cite
Schaerer D, Froehlich TK, Hamzic S, et al. A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies. J Pers Med. 2020;10(4)doi: 10.3390/jpm10040181.
Schaerer, D., Froehlich, T. K., Hamzic, S., Offer, S. M., Diasio, R. B., Joerger, M., Amstutz, U., & Largiadèr, C. R. (2020). A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies. Journal of personalized medicine, 10(4), . https://doi.org/10.3390/jpm10040181
Schaerer, Dominic, et al. "A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies." Journal of personalized medicine vol. 10,4 (2020). doi: https://doi.org/10.3390/jpm10040181
Schaerer D, Froehlich TK, Hamzic S, Offer SM, Diasio RB, Joerger M, Amstutz U, Largiadèr CR. A Novel Nomenclature for Repeat Motifs in the Thymidylate Synthase Enhancer Region and Its Relevance for Pharmacogenetic Studies. J Pers Med. 2020 Oct 19;10(4). doi: 10.3390/jpm10040181. PMID: 33086767; PMCID: PMC7712088.
Copy Download .nbib Format: NLM
[Morphology, histogenesis and classification of kidney tumors].

Urologia internationalis

LARGIADER F.
PMID: 13615930
Urol Int. 1958;6(4):272-367.

No abstract available.

Cite
LARGIADER F. Morphologie, Histogenese und Klassifikation der Nierentumoren. [Morphology, histogenesis and classification of kidney tumors]. Urol Int. 1958;6(4):272-367
LARGIADER, F. (1958). Morphologie, Histogenese und Klassifikation der Nierentumoren. [Morphology, histogenesis and classification of kidney tumors]. Urologia internationalis, 6(4), 272-367.
LARGIADER, F. "Morphologie, Histogenese und Klassifikation der Nierentumoren." [Morphology, histogenesis and classification of kidney tumors]. Urologia internationalis vol. 6,4 (1958): 272-367.
LARGIADER F. Morphologie, Histogenese und Klassifikation der Nierentumoren. [Morphology, histogenesis and classification of kidney tumors]. Urol Int. 1958;6(4):272-367. German. PMID: 13615930.
Copy Download .nbib Format: NLM
Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing.

Pathogens (Basel, Switzerland)

Karpstein T, Chaudhry S, Bresson-Hadni S, Hayoz M, Boubaker G, Hemphill A, Rufener R, Kaethner M, Schindler I, Aebi Y, Cunha AS, Largiadèr CR, Lundström-Stadelmann B.
PMID: 34684284
Pathogens. 2021 Oct 15;10(10). doi: 10.3390/pathogens10101335.

Drug-based treatment of alveolar echinococcosis (AE) with benzimidazoles is in most cases non-curative, thus has to be taken lifelong. Here, we report on a 56-year-old male AE patient who received standard benzimidazole treatment and biliary plastic stents, and additionally...

Cite
Karpstein T, Chaudhry S, Bresson-Hadni S, et al. Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing. Pathogens. 2021;10(10)doi: 10.3390/pathogens10101335.
Karpstein, T., Chaudhry, S., Bresson-Hadni, S., Hayoz, M., Boubaker, G., Hemphill, A., Rufener, R., Kaethner, M., Schindler, I., Aebi, Y., Cunha, A. S., Largiadèr, C. R., & Lundström-Stadelmann, B. (2021). Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing. Pathogens (Basel, Switzerland), 10(10), . https://doi.org/10.3390/pathogens10101335
Karpstein, Tanja, et al. "Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing." Pathogens (Basel, Switzerland) vol. 10,10 (2021). doi: https://doi.org/10.3390/pathogens10101335
Karpstein T, Chaudhry S, Bresson-Hadni S, Hayoz M, Boubaker G, Hemphill A, Rufener R, Kaethner M, Schindler I, Aebi Y, Cunha AS, Largiadèr CR, Lundström-Stadelmann B. Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing. Pathogens. 2021 Oct 15;10(10). doi: 10.3390/pathogens10101335. PMID: 34684284; PMCID: PMC8537204.
Copy Download .nbib Format: NLM
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study.

Allergy

Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M.
PMID: 34986501
Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05.

BACKGROUND: Serological tests are a powerful tool in the monitoring of infectious diseases and the detection of host immunity. However, manufacturers often provide diagnostic accuracy data generated through biased studies and the performance in clinical practice is essentially unclear.OBJECTIVES:...

Cite
Horn MP, Jonsdottir HR, Brigger D, et al. Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy. 2022;doi: 10.1111/all.15206.
Horn, M. P., Jonsdottir, H. R., Brigger, D., Damonti, L., Suter-Riniker, F., Endrich, O., Froehlich, T. K., Fiedler, M., Largiadèr, C. R., Marschall, J., Weber, B., Eggel, A., & Nagler, M. (2022). Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy, . https://doi.org/10.1111/all.15206
Horn, Michael P, et al. "Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study." Allergy vol. (2022). doi: https://doi.org/10.1111/all.15206
Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M. Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05. PMID: 34986501.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries